|
Main laboratory data and characteristics of the studied population |
|||||||||
| Diagnosis |
|||||||||
| CHC n 36 |
FL n 45 |
NASH n 42 |
|||||||
| Gender |
Mean |
SD |
Gender |
Mean |
SD |
Gender |
Mean |
SD |
|
|
|
|||||||||
| Age |
44.5 |
10.0 |
42.3 |
9.1 |
40.4 |
10.5 |
|||
| TGF-β1 ng/mL* |
87.5 |
39.5 |
129.1 |
45.4 |
116.8 |
42.2 |
|||
| CRP |
0.8 |
0.4 |
0.9 |
0.4 |
|||||
| ALT U/L# |
72.7 |
25.6 |
49.2 |
17.8 |
54.3 |
21.8 |
|||
| Ferritin ng/mL |
17 F |
203.6 |
86.5 |
21 F |
232.3 |
117.4 |
19 F |
279.8 |
150.3 |
| Ferritin ng/mL |
19 M |
396.4 |
153.5 |
24 M |
381.5 |
137.2 |
23 M |
357.2 |
132.3 |
| Waist Circumference (cm) |
21 F |
98 |
6.1 |
19 F |
100 |
4.7 |
|||
| Waist Circumference (cm) |
24 M |
105 |
6.3 |
23 M |
108 |
7.7 |
|||
| HOMA |
3.2 |
1.4 |
3.4 |
1.5 |
|||||
| Median |
Range |
Median |
Range |
Median |
Range |
||||
| BMI‡ |
26 |
22–30 |
29 |
27–32 |
29 |
27–32 |
|||
| Fibrosis score |
1 |
1–3 |
1 |
1–2 |
|||||
| US steatosis Score |
2 |
1–3 |
1 |
1–3 |
|||||
|
CHC, chronic hepatitis C; FL, fatty liver; NASH, non-alcoholic steatohepatitis; ALT, alanine aminotransferase; CRP, C reactive protein; TGF-β1, transforming growth factor beta1; BMI, body mass index; HOMA, homeostasis model assessment-insulin resistance index. * P < 0.001, FL versus CHC and 0.008, NASH versus CHC patients; # P < 0.001, CHC versus FL and NASH patients; ‡ P < 0.001, CHC versus FL and NASH patients. | |||||||||
Tarantino et al. Journal of Translational Medicine 2008 6:72 doi:10.1186/1479-5876-6-72 |
|||||||||